2015 to 2021 Saw Decrease in Incidence of Dementia
By Elana Gotkine HealthDay Reporter
FRIDAY, May 23, 2025 -- From 2015 to 2021, there was a decrease in the incidence of dementia, but an increase in prevalence, according to a study published online May 20 in The BMJ.
Beau Blass, M.P.H., from Duke University School of Medicine in Durham, North Carolina, and colleagues examined the incidence and prevalence of dementia in a nationally representative cohort of U.S. Medicare beneficiaries in a population-based study.
The researchers documented 5,025,039 incident cases of dementia from 2015 to 2021. There was a decrease in the overall age and sex standardized incidence between 2015 and 2021, from 3.5 to 2.8 percent. During the same time, prevalence increased from 10.5 to 11.8 percent. Higher age standardized incidence was seen for male versus female beneficiaries in 2015 (3.5 versus 3.4 percent); the difference increased by 2021 (2.9 versus 2.6 percent; estimated difference-in-difference, 0.94). In 2015, incidence was highest for Black beneficiaries, followed by Hispanic and White beneficiaries (4.2, 3.7, and 3.4 percent, respectively); in 2021, incidence was 3.1, 2.8, and 2.6 percent for Black, White, and Hispanic beneficiaries, respectively, with the differences between White and Black and White and Hispanic beneficiaries narrowing from 2015 to 2021 (estimated difference-in-differences, 0.92 and 0.88, respectively).
"The burden of dementia was unequally distributed, with the highest incidence and prevalence of dementia among Black beneficiaries and those living in socioeconomically deprived neighborhoods," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Broader Formulary Coverage Linked to Lower Odds of MS Relapse
FRIDAY, Aug. 8, 2025 -- Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published...
'Heart Age' Often Older Than Chronological Age
FRIDAY, Aug. 8, 2025 -- The Predicting Risk of Cardiovascular Disease Events (PREVENT) equation risk age is older than chronological age on average, with greater discordance for...
Nonlinear Inverse Association Seen for Step Count, Peak Cadence With MACE
THURSDAY, Aug. 7, 2025 -- There are nonlinear, inverse associations for step count and peak cadence with the risk for major adverse cardiovascular events (MACE) among individuals...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.